Trials / Completed
CompletedNCT02676401
An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 241 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and efficacy of MT-3995 administered over the longer term, following MT-3995-J05 study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-3995 Low | |
| DRUG | MT-3995 Middle | |
| DRUG | MT-3995 High |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-08-01
- First posted
- 2016-02-08
- Last updated
- 2017-09-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02676401. Inclusion in this directory is not an endorsement.